Originally published July 24 2005
Pfizer says tests indicate no link between Viagra and risk of blindness
by Mike Adams, the Health Ranger, NaturalNews Editor
Although the Food and Drug Administration cites 38 reports of non-arteritic anterior ischemic optic neuropathy (NAION) among users of Viagra, the erectile dysfunction drug's manufacturer, Pfizer, says their tests indicate no relation between the drug and blindness, but are still updating the drug's label to warn of it.
Pfizer Inc. said that a review concluded that Viagra doesn't increase patients' risk of blindness but that it is still working with federal regulators to update the drug's label to reflect rare reports of vision loss.
Last month, the U.S. Food and Drug Administration said it had 38 reports of blindness caused by a a condition called NAION or non-arteritic anterior ischemic optic neuropathy among users of Viagra.
But Pfizer said it conducted a review of all post-marketing ocular event reports has concluded that there is no evidence of increased risk of blindness among patients taking Viagra.
While the FDA has concluded that no causal relationship between Viagra and NAION has been established, Pfizer has agreed to include on the Viagra label that these reports exist in order to inform physicians and patients.
"After more than 10 years of rigorous clinical study and worldwide safety monitoring of a medicine used by more than 27 million men, there is no evidence to suggest a link between Viagra and blindness or other serious ocular events," said Joseph Feczko, Pfizer's chief medical officer.
"In addition, several studies specifically looking into the effect of Viagra in the eye by Pfizer as well as independent ophthalmologic experts found Viagra to have no serious adverse effects on the eye."
The FDA reported there were instances of NAION among those taking Cialis, which is made by Eli Lilly & Co. and ICOS Corp. as well as Levitra, which is marketed by Bayer AG, GlaxoSmithKline PLC and Schering-Plough Corp.
"We are in the process of evaluating the data and reviewing the analyses," he said.
"We have already conducted exhaustive studies involving 60,000 patients and there has never been one case of sudden blindness."
All content posted on this site is commentary or opinion and is protected under Free Speech. Truth Publishing LLC takes sole responsibility for all content. Truth Publishing sells no hard products and earns no money from the recommendation of products. NaturalNews.com is presented for educational and commentary purposes only and should not be construed as professional advice from any licensed practitioner. Truth Publishing assumes no responsibility for the use or misuse of this material. For the full terms of usage of this material, visit www.NaturalNews.com/terms.shtml